Early gastric cancer: endoscopic mucosal resection

25.00

HITOSHI KONDO, TAKUJI GOTODA, HIROYUKI ONO, ICHIRO ODA, HAJIME YAMAGUCHI, DAIZO SAITO, SHIGEAKI YOSHIDA

Ann. Ital. Chir., LXXII, 1, 2001

La mia nuova descrizione qui!

Price of a print issue €25.00

In Japan, endoscopic mucosal resection (EMR) is now accepted as a treatment option for cases of early gastric cancer (EGC) with minimum probability of associated lymph node metastasis. In National Cancer Center Hospital (NCCH), EMR is currently applied to patients with early cancers up to 30mm diameter that were of intestinal type, and were superficially elevated and/or depressed (Type I, IIa and IIc) but without ulceration or definite signs of submucosal invasion. Four hundred seventy nine lesions of EGC in 449 patients were treated by EMR from 1987 through 1998. Submucosal invasion was found on subsequent pathologic examination in 74 lesions, and surgery was recommended. Sixty nine percent of intramucosal cancer was resected with a clear margin, which was therefore judged to be a “complete resection”. Local recurrence in the stomach occurred in 2% (5 lesions) with complete resection and in 17% (18 lesions) without complete resection treated conservatively or endoscopically, and all were subsequently treated with curative intent.